Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial.

PMID:29650420
Rutkowski P , Gaston L , Borkowska A , Stacchiotti S , Gelderblom H , Baldi GG , Palmerini E , Casali P , Gronchi A , Parry M , Campanacci DA , Scoccianti G , Wagrodzki M , Ferrari S , Dijkstra S , Pieńkowski A , Grimer R
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Giant cell tumor of bone (GCTB) is an osteolytic, locally aggressive, rarely metastazing bone tumor. This is a retrospective study evaluating a large series of GCTB patients treated with denosumab in routine practice in 6 European reference centers.


Copyright(C) 2006 BIOIMPACT Co., Ltd. All Rights Reserved